PTJ
CRL icon

Paul Tudor Jones’s Charles River Laboratories CRL Stock Holding History

Paul Tudor Jones’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,100
Closed -$707K – 3672
2026
Q1 		$707K Buy
+4,100
New +$760K ﹤0.01% 2601
2025
Q4 		– Sell
-4,700
Closed -$735K – 3569
2025
Q3 		$735K Buy
4,700
+300
+7% +$47.6K ﹤0.01% 2473
2025
Q2 		$668K Buy
4,400
+2,400
+120% +$320K ﹤0.01% 2400
2025
Q1 		$301K Sell
2,000
-300
-13% -$50.3K ﹤0.01% 2587
2024
Q4 		$425K Sell
2,300
-400
-15% -$77.1K ﹤0.01% 2352
2024
Q3 		$532K Buy
+2,700
New +$561K ﹤0.01% 1996
2023
Q1 		– Sell
-5,400
Closed -$1.18M – 2498
2022
Q4 		$1.18M Buy
5,400
+3,200
+145% +$699K 0.02% 994
2022
Q3 		$433K Buy
+2,200
New +$475K 0.01% 1500

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Paul Tudor Jones's CRL Position: Q1 2026 in Review

Paul Tudor Jones sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 4,782 shares — an estimated $887K sold.

Paul Tudor Jones first reported a position in CRL in Q2 2013 and held it in 35 quarters. The position peaked at $25.8M in Q2 2025. 559 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Paul Tudor Jones reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 4,782 Charles River Laboratories shares in Q1 2026, an estimated $887K.
  • Paul Tudor Jones first reported a position in Charles River Laboratories in Q2 2013 and held it in 35 quarters.
  • Paul Tudor Jones's Charles River Laboratories position peaked at $25.8M in Q2 2025.
  • 559 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.